Clinical Trials Logo

Filter by:
NCT ID: NCT05114629 Completed - Electromyography Clinical Trials

Biomechanics of Adaptive Rowing in Active and Inactive Manual Wheelchair Users

Start date: September 14, 2021
Phase:
Study type: Observational

This research is being performed to characterize the rowing stroke in active and inactive individuals who use a manual wheelchair. The investigators will be looking at muscle activity of four shoulder muscles (upper trapezius, lower trapezius, serratus anterior, and posterior deltoid) and motion of the arms, shoulder blade, and trunk during rowing. This will be done for three rowing conditions (1: adapted rowing ergometer, 2: rowing ergometer from a chair, 3: standard seated row exercise using an elastic band [TheraBand]). The investigators are also looking at shoulder strength, range of motion, quality of life, and community participation.

NCT ID: NCT05114590 Completed - Clinical trials for Type 2 Diabetes Mellitus

Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Very Uncontrolled Type 2 Diabetes Mellitus

Soli-CGM
Start date: January 27, 2022
Phase: Phase 4
Study type: Interventional

The purpose of the study was to demonstrate if iGlarLixi (Soliqua 100/33) would improve glycemic control (as measured by Time in Range) and glycemic variability in participants with very uncontrolled (HbA1c ≥ 9%) type 2 Diabetes Mellitus (T2DM) while on at least 2 oral antidiabetic drugs [OADs] with or without a glucagon-like peptide 1 receptor agonist [GLP1 RA]), as measured by continuous glucose monitoring (CGM). The total study duration per participant was approximately 22 weeks. Three site visits, 3 site or home visits, and up to 13 phone contacts were scheduled. - A screening period of up to 2 weeks - A run-in period of up to 2 weeks, including the baseline period - A 16-week, open-label treatment period - A 2-week post-treatment safety follow-up period

NCT ID: NCT05114577 Completed - Sleep Clinical Trials

Recovery Sleepers: A Pilot Study of a Sleep Health Intervention for College Students in Recovery

Start date: October 24, 2021
Phase: N/A
Study type: Interventional

The purpose of this research study is to examine how to improve sleep in college students in recovery from substance use disorder(s). This study is a pilot test of an experimental program called Recovery Sleepers (RS) to explore its feasibility and how well it works to improve sleep, wellbeing, and cravings.

NCT ID: NCT05114564 Completed - Myopia Clinical Trials

Evaluation of the Performance of Monthly Replacement Sphere Lens Designs in Habitual Soft Contact Lens Wearers

Start date: November 19, 2021
Phase: N/A
Study type: Interventional

The objective of the study is to evaluate the clinical performance of two monthly silicone hydrogel contact lenses in habitual wearers of frequent replacement (FRP) lenses when worn for one month.

NCT ID: NCT05114525 Completed - Breast Cancer Clinical Trials

Analysis of Patient Understanding of Radiation Therapy Among Patients With Breast Cancer

Start date: January 20, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to conduct a descriptive feasibility study of assessing how patients retain and understand information regarding radiation therapy obtained from an initial consult visit. This study will also pilot the use of visual aids and assess their utility to patients during a consult. The study will provide a baseline to conduct larger studies that will later incorporate additional patient education tools to assess changes in patient understanding of information received in radiation oncology patient consultations.

NCT ID: NCT05114486 Completed - Presbyopia Clinical Trials

Safety & Efficacy of Pilocarpine Ophthalmic Spray for Temporary Improvement of Near Vision in Presbyopic Adults

VISION-2
Start date: November 3, 2021
Phase: Phase 3
Study type: Interventional

Volunteer participants are evaluated for eligibility during a Screening Visit; those meeting study inclusion/exclusion criteria are scheduled for 2 treatment visits. At each treatment visit, 1 of the 2 study treatments is self-administered to both eyes. Afterwards, efficacy and safety assessments are performed over a 3-hour period.

NCT ID: NCT05113979 Completed - Refractive Errors Clinical Trials

Early Feasibility Study to Evaluate the AccuraSee in Correcting Residual Refractive Errors After Cataract Surgery

Start date: March 9, 2020
Phase:
Study type: Interventional

To determine if the intraocular pseudophakic contact lens (IOPCL), referred to as the AccuraSee, corrects residual refractive errors after cataract surgery using a plus powered lens in subjects with ocular pathology previously implanted with a Bausch and Lomb LI61AO or LI61SE monofocal posterior chamber intraocular lens (PCIOL) and to confirm its positional stability and adherence relative to the PCIOL.

NCT ID: NCT05113953 Completed - Clinical trials for Binge-Eating Disorder

A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder

Start date: December 16, 2021
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to assess the efficacy of 2 doses of centanafadine sustained-release (SR) (200 milligrams [mg] and 400 mg total daily dose [TDD]) compared with placebo in adults with moderate to severe binge eating disorder (BED).

NCT ID: NCT05113797 Completed - Balance Clinical Trials

Use of the OPTIMAL Theory of Motor Learning With the Lower Quarter Y-Balance Test

Start date: November 13, 2021
Phase: N/A
Study type: Interventional

Assessing and improving movement quality are important components of rehabilitation. The Lower Quarter Y-Balance Test (YBT-LQ) is a balance test used to assess dynamic balance in healthy adults, athletes, and those who are rehabilitating a lower extremity injury. Performing the YBT-LQ requires utilization of different strategies. It is unknown how different practice conditions will affect dynamic balance learning or performance on YBT-LQ. This study aims to compare the influence of OPTIMAL motor learning practice with standard practice conditions on YBT-LQ measurements.

NCT ID: NCT05113771 Completed - Clinical trials for Treatment Resistant Depression

A Biomarker-Guided, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With Treatment-Resistant Depression

ENLIGHTEN
Start date: June 29, 2022
Phase: Phase 2
Study type: Interventional

This study will be conducted as a randomized, double-blind, placebo-controlled, multi-center Phase 2b study. Approximately 180 subjects with treatment resistant depression who meet all eligibility criteria will be enrolled.